AR and prostate carcinoma: Notably, NANOG was demonstrated to reprogramme prostate cancer cells by repressing the AR signalling axis and activating its own distinct transcriptional programme as well as engaging that of others such as MYC, leading to acquisition of a castration-resistant stem cell-like state [13].